4//SEC Filing
Moukheibir Catherine 4
Accession 0001213900-25-052366
CIK 0001821586other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 9:06 AM ET
Size
5.8 KB
Accession
0001213900-25-052366
Insider Transaction Report
Form 4
Moukheibir Catherine
Director
Transactions
- Award
Option to Buy
2025-06-05+6,682→ 6,682 totalExercise: $48.83Exp: 2035-06-05→ Class A ordinary shares, par value $0.0001 per share (6,682 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 6,682 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 5, 2026 and (ii) the date of the Issuer's next annual general meeting of shareholders, subject to the Reporting Person's continued service to the Issuer.
Documents
Issuer
MoonLake Immunotherapeutics
CIK 0001821586
Entity typeother
Related Parties
1- filerCIK 0001772130
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 9:06 AM ET
- Size
- 5.8 KB